What is NGL Fine-Chem Ltd (NGLFINE) share price return in the past 10 years?

NGL Fine-Chem Ltd share price has appreciated 26.9% annually (CAGR) over the past ten years.

What is the share price of NGL Fine-Chem Ltd (NGLFINE)?

Company share prices are keep on changing according to the market conditions. The current trading price of NGL Fine-Chem Ltd (NGLFINE) on 04-Jun-2026 16:59:59 at 16:59 is 2586.85.

What is the P/E ratio of NGL Fine-Chem?

The latest standalone P/E ratio of NGL Fine-Chem as of 04-Jun-2026 is 38.39.

What is the P/B ratio of NGL Fine-Chem Ltd (NGLFINE)?

The latest standalone P/B ratio of NGL Fine-Chem Ltd (NGLFINE) as of 04-Jun-2026 is 5.00.

What is the 52-week high and low of NGL Fine-Chem Ltd (NGLFINE)?

The 52-week high of NGL Fine-Chem Ltd (NGLFINE) is Rs. 3000.00 and the 52-week low is Rs. 985.05.

NGL Fine-Chem Ltd (NGLFINE) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: NGL Fine-Chem Ltd (NGLFINE)
Brand: NGL Fine-Chem

NGL Fine-Chem Ltd (NGLFINE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524774 NSE: NGLFINE Pharmaceuticals & Drugs | Small Cap | NGL Fine-Chem Share Price

NGL Fine-Chem Ltd (NGLFINE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524774 NSE: NGLFINE Pharmaceuticals & Drugs | Small Cap | NGL Fine-Chem Share Price

Key Metrics

Valuation Multiples

Market Cap

₹1,598 Cr.

Current Price

₹2,586.9

52-Week Low / High

₹985 / 3,000

TTM EPS

₹67.4

TTM Sales

₹489 Cr.

Book Value per Share

₹517.9

P/E Ratio

38.39

Higher than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

5.00

In line with its 5-year historical median

Price to Sales (P/S)

3.27

Lower than its 5-year historical median

EV/EBITDA

22.61

In line with its 5-year historical median

Dividend Yield

0.16%

Profitability Efficiency

Return on Equity (ROE)

6.69%

Underperforms industry median

Return on Capital Employed (ROCE)

8.29%

Underperforms industry median

Return on Assets (ROA)

4.66%

Operating Profit Margin

7.4%

Net Profit Margin

5.05%

Gross Profit Margin

9.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

9.22%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-40.64%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-52.93%

Asset Quality

Promoter Holding

72.74%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹317 Cr.

Equity

₹3.1 Cr.

Face Value

₹5

All Time Low / High

₹0.40 / 3789.45

NGL Fine-Chem stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Fair

Check Valuation charts

Price Trend

Strong

Check Price chart

Q.1 Is NGL Fine-Chem Ltd a good quality company?

NGL Fine-Chem Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does NGL Fine-Chem Ltd performance compare with that of its Peers?

Q.1 Revenue growth of NGL Fine-Chem Ltd vs industry peers?

NGL Fine-Chem Ltd revenue CAGR is 18.75%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of NGL Fine-Chem Ltd?

Promoters hold 72.74% of the NGL Fine-Chem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of NGL Fine-Chem Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 26.6% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	37.1%	33.8%	21.7%	27.6%	13.7%	51.9%	34.7%	11.5%	18.9%	8.3%	-
Value Creation Index ⓘ	1.7	1.4	0.6	1.0	0.0	2.7	1.5	-0.2	0.4	-0.4	-
Growth Parameters ⓘ
Sales ⓘ	96.3	99.7	114	153	152	258	319	275	329	359	489
Sales YoY Gr.	-	3.6%	14%	34.8%	-0.7%	69.7%	23.4%	-13.7%	19.6%	9.2%	-
Adj EPS ⓘ	18.5	22.9	18.6	29	16.6	88.1	84.6	29.4	58.4	26.2	67.4
YoY Gr.	-	24.2%	-18.9%	56%	-42.7%	430%	-4%	-65.2%	98.4%	-55.2%	-
BVPS (₹) ⓘ	71.6	96.2	116.6	149.1	163.8	251.6	334.4	365	425.4	452.6	517.9
Adj Net Profit ⓘ	11.4	14.2	11.5	17.9	10.3	54.5	52.3	18.2	36.1	16.2	42
Cash Flow from Ops. ⓘ	8.4	9.9	22.4	8.9	19.6	26.6	15.8	31.9	11.1	17	-
Debt/CF from Ops. ⓘ	1.7	2.3	1.2	3.1	1.4	0.6	1.9	1	3.1	4.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	15.8%	18.8%	4.1%	9.2%
Adj EPS ⓘ	4%	9.5%	-32.4%	-55.2%
BVPSⓘ	22.7%	22.5%	10.6%	6.4%
Share Price	26.9%	6.1%	20.7%	145.7%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	29.6	27.3	17.5	21.8	10.6	42.4	28.9	8.4	14.8	6	13.9
Op. Profit Mgn % ⓘ	22.8	25.6	19	21.1	15.2	29.8	20.7	10.4	13.6	7.4	12.1
Net Profit Mgn % ⓘ	11.8	14.2	10.1	11.7	6.8	21.1	16.4	6.6	11	4.5	8.5
Debt to Equity ⓘ	0.3	0.4	0.4	0.3	0.3	0.1	0.2	0.1	0.1	0.3	0.2
Working Cap Days ⓘ	160	187	198	167	184	132	166	216	186	191	91
Cash Conv. Cycle ⓘ	74	81	65	55	79	49	74	99	76	73	43

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	96	100	114	153	152	258	319	275	329	359
Operating Expenses ⓘ +	74	74	92	121	131	181	253	246	284	333
Manufacturing Costs	13	15	18	22	27	33	50	50	63	69
Material Costs	41	38	46	63	65	103	148	140	155	185
Employee Cost	11	14	18	21	24	27	33	34	41	51
Other Costs ⓘ	10	8	10	15	16	19	22	23	25	28
Operating Profit ⓘ	22	25	22	32	21	77	66	29	45	27
Operating Profit Margin (%)	22.8%	25.5%	19.0%	21.1%	13.7%	29.8%	20.7%	10.4%	13.6%	7.4%
Other Income ⓘ +	0	1	3	4	3	9	13	8	16	10
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2	1	2	3	3	2	2	2	2	3
Depreciation ⓘ	3	3	5	6	7	7	8	8	8	9
Profit Before Tax ⓘ	18	23	18	28	14	76	69	27	51	24
Tax ⓘ	6	8	5	7	4	21	17	6	12	6
Profit After Tax	11	15	13	20	11	55	52	20	39	18
PAT Margin (%)	11.8%	14.9%	11.1%	13.1%	7.0%	21.5%	16.4%	7.3%	11.7%	5.1%
Adjusted EPS (₹)	18.5	24.1	20.5	32.6	17.2	89.8	84.6	32.6	62.4	29.4
Dividend Payout Ratio (%)	0%	0%	0%	5.40%	10.20%	2%	2.10%	5.40%	2.80%	6%

Valuation of NGL Fine-Chem - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	44	59	72	92	101	155	207	226	263	280
Share Capital ⓘ	3	3	3	3	3	3	3	3	3	3
Reserves ⓘ	41	56	69	89	98	152	203	222	260	277
Debt +	13	20	24	23	23	11	27	30	32	72
Long Term Debt	0	9	12	8	8	6	3	2	1	25
Short Term Debt	12	11	11	15	15	5	23	28	32	47
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	14	14	24	16	21	27	35	23	47	54
Others Liabilities ⓘ	7	17	14	18	11	12	10	9	11	20
Total Liabilities ⓘ	78	111	133	149	156	206	278	288	353	426
Fixed Assets
Net Fixed Assets ⓘ +	24	25	56	61	61	58	59	59	60	120
Gross Block	38	28	64	74	81	85	92	100	108	177
Accumulated Depreciation	13	3	7	13	20	27	33	41	48	57
CWIP ⓘ	2	16	3	0	0	1	6	26	46	50
Investments ⓘ	3	6	6	9	14	33	32	43	57	63
Inventories	10	12	17	19	28	38	55	27	43	49
Trade Receivables	32	30	28	33	26	38	65	65	83	80
Cash Equivalents	2	2	4	3	3	5	1	13	2	6
Others Assets ⓘ	4	20	19	25	23	34	60	54	63	58
Total Assets ⓘ	78	111	133	149	156	206	278	288	353	426

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	8	10	22	9	20	27	16	32	11	17
PBT ⓘ	18	23	18	28	14	76	69	27	51	24
Adjustment ⓘ	3	3	5	8	11	3	7	6	-1	9
Changes in Working Capital ⓘ	-6	-8	4	-19	-2	-32	-43	6	-26	-10
Tax Paid ⓘ	-6	-8	-5	-7	-4	-21	-17	-6	-12	-6
Cash Flow From Investing Activity ⓘ +	-10	-10	-21	-10	-19	-24	-16	-24	-17	-16
Capex	-10	-18	-23	-14	-7	-5	-14	-29	-28	-73
Net Investments	0	1	0	0	-4	1	0	0	0	0
Others ⓘ	0	7	2	5	-8	-20	-2	5	11	57
Cash Flow From Financing Activity ⓘ +	2	0	0	0	-1	-1	-1	-1	-1	-1
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-1	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	-1	-1	-1	-1	-1	-1
Others ⓘ	3	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	0	-0	1	-1	-0	2	-1	7	-7	0

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	29.59	28.73	19.22	24.52	10.97	43.22	28.86	9.31	15.78	6.69
ROCE (%)	37.14	33.8	21.68	27.63	13.65	51.9	34.71	11.5	18.93	8.29
Asset Turnover Ratio	1.44	1.13	0.95	1.08	1	1.43	1.32	0.97	1.03	0.92
PAT to CFO Conversion(x)	0.73	0.67	1.69	0.45	1.82	0.49	0.31	1.6	0.28	0.94
Working Capital Days
Receivable Days	102.90	107.30	91.20	72.40	71.10	45.10	58.70	86.30	82.30	82.80
Inventory Days	39	37.40	45.20	42.20	55.80	46.50	53.30	54.50	38.60	46.60
Payable Days	122.50	123.20	145.30	110.70	97.40	73.50	65.50	70.50	82.90	99.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

NGL Fine-Chem Ltd FAQs

The current trading price of NGL Fine-Chem on 04-Jun-2026 16:59 is ₹2,586.9.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of NGL Fine-Chem stood at ₹1,598.2 Cr

The latest P/E ratio of NGL Fine-Chem as of 03-Jun-2026 is 38.39.

The latest P/B ratio of NGL Fine-Chem as of 03-Jun-2026 is 5.00.

The 52-week high of NGL Fine-Chem is ₹3,000 and the 52-week low is ₹985.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of NGL Fine-Chem is ₹489 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that NGL Fine-Chem Ltd is a average quality company.

The key valuation ratios of NGL Fine-Chem Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of NGL Fine-Chem Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About NGL Fine-Chem Ltd

NGL Fine-chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility.

Its business is modelled around the changing customer demands and their ability to offer value-added innovative solutions to meet and even exceed these demands.

Utilizing its expertise in complex multi-stage organic synthesis, it continues to expand the product portfolio with new products.

It has established a strong presence in global pharmaceutical companies with its commitment to competitive prices, delivery schedules, international quality standards and constant technological upgradation.

NGL Fine-chem Ltd has a strong focus on developing intellectual property as a key differentiator and as a platform for further growth up the pharma value chain. It respect intellectual property and invest in developing it as a key growth driver for the future.

Product range of the company includes:

Pharmaceutical like Diminazene Aceturate, Diminazene Diaceturate, Homidium Chloride, Nitroxynil, Clorsulon, Homidium Bromide, Parvaquone, Carprofen, Buparvaquone and Isometamidium Chloride Hydrochloride for:

Animal health
Human health
Intermediate- 4 Aminobenzamidine Dihydrochloride, 3 Aminobenzamidine Dihydrochloride, Ezetimibe Intermediates etc
Finished dosages form- Homidium Chloride Tablets, Diminazene Aceturate Granules

Achievements/ recognition

An ISO 9001:2000 accredited company

NGL Fine-Chem Ltd (NGLFINE)

NGL Fine-Chem Ltd (NGLFINE)

NGL Fine-Chem stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of NGL Fine-Chem - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

NGL Fine-Chem Ltd FAQs

About NGL Fine-Chem Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

NGL Fine-Chem Ltd (NGLFINE)

NGL Fine-Chem Ltd (NGLFINE)

NGL Fine-Chem stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of NGL Fine-Chem - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

NGL Fine-Chem Ltd FAQs

What is the share price of NGL Fine-Chem?

What is the market cap of NGL Fine-Chem?

What is the P/E ratio of NGL Fine-Chem?

What is the P/B ratio of NGL Fine-Chem?

What is the 52-week high and low of NGL Fine-Chem?

What is the TTM revenue of NGL Fine-Chem?

Is NGL Fine-Chem Ltd a good quality company?

Is NGL Fine-Chem Ltd undervalued or overvalued?

Is NGL Fine-Chem Ltd a good buy now?

About NGL Fine-Chem Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.